Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €5.04 EUR
Change Today -0.04 / -0.79%
Volume 26.1K
THR On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
Berlin
As of 11:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - THROMBOGENICS NV (THR)

ThromboGenics NV to Report Q3, 2015 on Nov 05, 2015
CapIQ 11/05/2015 5:00 AM ET
ThromboGenics NV to Report First Half, 2015 on Aug 26, 2015
CapIQ 11/05/2015 5:00 AM ET
ThromboGenics NV to Report Q1, 2015 on May 21, 2015
CapIQ 11/05/2015 5:00 AM ET

2013 revenues at ThromboGenics NV totaled €112.8M EUR, while annual earnings equaled €0.71 per share.

Quarterly Earnings & Estimates - THROMBOGENICS NV (THR)

Chart not available

No earnings announcements are currently available for THROMBOGENICS NV.

Annual Earnings & Estimates - THROMBOGENICS NV (THR)

Actuals vs. Estimates for THROMBOGENICS NV THR

ThromboGenics NV's Annual Earnings

ThromboGenics NV reported annual 2013 earnings of €0.71 per share on 03/19/2014.

Quarterly Revenues - THROMBOGENICS NV (THR)

Chart not available

Annual Revenues - THROMBOGENICS NV (THR)

Actuals vs. Estimates for THROMBOGENICS NV THR

ThromboGenics NV's Annual Revenues

ThromboGenics NV had revenues for the full year 2013 of €112.8M EUR. This was 50.2% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THR:BB €5.04 EUR -0.04

THR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for THR.
View Industry Companies
 

Industry Analysis

THR

Industry Average

Valuation THR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.0x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THROMBOGENICS NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.